z-logo
Premium
Study finds some unendorsed practices in first‐episode schizophrenia prescribing
Publication year - 2015
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30026
Subject(s) - schizophrenia (object oriented programming) , psychiatry , medicine , medical prescription , depression (economics) , antidepressant , antipsychotic , anxiety , pharmacology , economics , macroeconomics
Nearly 40% of a group of 404 participants in a first‐episode schizophrenia study were evaluated as possibly benefiting from a change in their psychotropic prescriptions, with issues such as some patients receiving more than one antipsychotic or receiving an antidepressant despite a lack of a depression indication. The study results, published online Dec. 4, 2014, in the American Journal of Psychiatry , suggest that some prescribers do not tailor their medication decision‐making to the specific needs of first‐episode schizophrenia patients, as recommended in schizophrenia treatment practice guidelines.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here